Noble, J E; Cerasoli, E (2007) Fluorescent labelling of protein analysis. NPL Report. AS 10
Moore, J D; Noble, J E; Nugent, P G; Cerasoli, E; Lamarre, B M; Bailey, M J A (2007) Towards the development of protein-protein interaction standards to improve the comparability of protein interaction measurements. NPL Report. AS 8
Bailey, M J A B; Cerasoli, E; Gaines Das, R*; Hills, A; Jones, C*; Kumarswami, N; Lamarre, B; LePevelen, D*; Moore, J D; Nugent, P; Rakowska, P; Robinson, C J*; Silva, M*; Tranter, G*; Wheeler, J* (2007) Strengthening quality control of biopharmaceutical products through the establishment of structure-function relationships. NPL Report. AS 5
Pyne, A; Pfeil, M P; Bennett, I*; Ravi, J; Iavicoli, P*; Lamarre, B; Roethke, A*; Ray, S; Jiang, H B*; Bella, A; Reisinger, B*; Yin, D; Little, B*; Munoz-Garcia, J C*; Cerasoli, E; Judge, P J*; Faruqui, N; Calzolai, L*; Henrion, A*; Martyna, G J*; Grovenor, C R M*; Crain, J; Hoogenboom, B W*; Watts, A*; Ryadnov, M G (2017) Engineering monolayer poration for rapid exfoliation of microbial membranes. Chem. Sci., 8 (2). pp. 1105-1115.
Cerasoli, E; Ravi, J; Garfagnini, T; Gnaniah, S J P; le Pevelen, D*; Tranter, G E (2014) Temperature denaturation and aggregation of a multi-domain protein (IgG1) investigated with an array of complementary biophysical methods. Anal. Bioanal. Chem., 406 (26). pp. 6577-6586.
Ryan, L; Lamarre, B; Diu, T*; Ravi, J; Judge, P J*; Temple, A*; Carr, M*; Cerasoli, E; Su, B*; Jenkinson, H F*; Martyne, G*; Crain, J; Watts, A*; Ryadnov, M G (2013) Anti-antimicrobial peptides folding-mediated host defense antagonists. J. Biol. Chem., 288 (28). pp. 20162-20172.
Cerasoli, E; Ravi, J; Gregor, C*; Hussain, R*; Siligardi, G*; Martyna, G*; Crain, J; Ryadnov, M G (2012) Membrane mediated regulation in free peptides of HIV-1 gp41: minimal modulation of the hemifusion phase.. Phys. Chem. Chem. Phys., 14 (3). pp. 1277-1285.
Gregor, C R*; Cerasoli, E; Schouten, J*; Ravi, J; Slootstra, J*; Horgan, A M; Martyna, G J*; Ryadnov, M G; Davis, P*; Crain, J (2011) Antibody recognition of a human chorionic gonadrtropin epitope (hCG beta(66-80)) depends on local structure retained in the free peptide. J. Biol. Chem., 286 (28). pp. 25016-25026.
Gregor, C R*; Cerasoli, E; Tulip, P R*; Ryadnov, M G; Martyna, G J*; Crain, J (2011) Autonomous folding in the membrane proximal HIV peptide gp41(659-671): pH tuneability at micelle interfaces. Phys. Chem. Chem. Phys., 13 (1). pp. 127-135.
Ravi, J; Hills, A E; Cerasoli, E; Rakowska, P D; Ryadnov, M G (2011) FTIR markers of methionine oxidation for early detection of oxidized protein therapeutics. Eur. Biophys. J., 40 (3). pp. 339-345.
Jazek, J*; Rides, M; Derham, B*; Moore, J; Cerasoli, E; Simler, R*; Perez-Ramirez, B* (2011) Viscosity of concentrated therapeutic protein compositions. Adv. Drug Delivery Rev., 63 (13). pp. 1107-1117.
Tulip, P R*; Gregor, C R*; Troitzsch, R Z*; Martyna, G J*; Cerasoli, E; Tranter, G*; Crain, J (2010) Conformational plasticity in an HIV-1 antibody epitope. J. Phys. Chem. B, 114 (23). pp. 7942-7950.
Cerasoli, E; Rakowska, P D; Horgan, A M; Ravi, J; Bradley, M*; Vincent, B*; Ryadnov, M G (2010) MiS-MALDI: microgel-selected detection of protein biomarkers by MALDI-ToF mass spectrometry. Mol. Biosyst., 6 (11). pp. 2214-2217.
Ryadnov, M G; Cerasoli, E; Martyna, G J*; Crain, J (2010) Translational biophysics: the physical sciences in molecular medicine. Future Med. Chem., 2 (11). pp. 1633-1639.
Silva, M M C G*; Lamarre, B; Cerasoli, E; Rakowska, P; Hills, A; Bailey, M J A; Wheeler, J X*; Burns, C J*; Gaines-Das, R E*; Jones, C*; Robinson, C J* (2008) Physicochemical and biological assays for quality control of biopharmaceuticals: Interferon alfa-2 case study. Biologicals, 36 (6). pp. 383-392.
Noble, J E; Wang, L*; Cerasoli, E; Knight, A E; Porter, R A*; Gray, E*; Howe, C*; Hannes, E*; Corbisier, P*; Wang, J*; Wu, L*; Altieri, I*; Patriarca, M*; Hoffman, A*; Resch-Genger, U*; Ebert, B*; Voigt, J*; Shigeri, Y*; Vonsky, M S*; Konopelko, L A*; Gaigalas, A K*; Bailey, M J A (2008) An international comparability study to determine the sources of uncertainty associated with a fluorescent ELISA. Clin. Chem. Lab. Med., 46 (7). pp. 1033-1045.